Clinical Trials and Treatment Studies

Google Scholar Citations

Publications: Clinical Trials and Treatment Studies


  1. Berry-Kravis, E., Hessl, D., Coffey, S., Hervey, C., Schneider, A., Yuhas, J., Hutchinson, J., Snape, M., Tranfaglia, M., Nguyen, D.V. and Hagerman, R.J. (2009) A pilot open-label single-dose trial of fenobam in adults with fragile X syndrome. Journal of Medical Genetics, 46, 266-271.
  2. Utari, A., Chonchaiya, W., Rivera, S.M., Schneider, A., Faradz, S., Ethell, I.M., Nguyen, D.V. and Hagerman, R.J. (2010) Side effects of minocyline treatment in patients with fragile X syndrome and exploration of outcome measures. American Journal on Intellectual and Developmental Disabilities, 115, 433-443.
  3. Ortigas MC, Bourgeois JA, Schneider A, Olichney J, Nguyen DV, Cogswell JB, Hall DA, Hagerman RJ. (2010) Improving fragile X-associated tremor/ataxia syndrome symptoms with memantine and venlafaxine. Journal of Clinical Psychopharmacology, 30, 642-644.
  4. Winarni TI, Chonchaiya W, Au J, Adams E, Mu Y, Nguyen DV, Hagerman RJ (2012) Sertraline May Improve Language Developmental Trajectory in Young Children with Fragile X Syndrome: A Retrospective Chart Review. Autism Research and Treatment, 2012:104317, 8 pages.
  5. Berry-Kravis E, Hessl D, Rathmell B, Zarevics P, Cherubini M, Walton-Bowen K, Mu Y, Nguyen DV, Gonzales-Heydrich I, Wang P, Carpenter R, Bear M, Hagerman RJ (2012) Effects of STX209 (arbaclofen) on neurobehavioral function in children and adults with fragile X syndrome: A randomized, controlled, Phase 2 trial. Science Translational Medicine, 4, 152:127.
  6. Leigh MJ, Nguyen DV, Mu Y, Winarni TI, Hessl DR, Rivera SM, Chechi T, Polussa J, Tassone F, Hagerman RJ (2013) A randomized double blind, placebo controlled trial of minocycline in children and adolescents with fragile X syndrome. Journal of Developmental and Behavioral Pediatrics, 34, 147-155.
  7. Seritan AL, Nguyen DV, Mu Y, Tassone F, Bourgeois JA, Schneider A, Cogswell J, Cook K, Leehey M, Grigsby J, Olichney JM, Adams P, Legg W, Zhang L, Hagerman PJ, Hagerman RJ (2014) Memantine for fragile X-associated tremor/ataxia syndrome (FXTAS): A randomized, double-blind, placebo-control trial. Journal of Clinical Psychiatry, 75, 264-271.
  8. Hess LG, Fitzpatrick SE, Nguyen DV, Chen Y, Gaul K, Schneider A, Chitwood KL, Eldeeb M, Siyahian S, Polussa J, Hessl D, Hagerman RJ (2016) A randomized double-blind, placebo-controlled trial of sertraline in young children with fragile X syndrome. Journal of Developmental & Behavioral Pediatrics, 37(8):619-28.
  9. Biegler K, Mollica R, Sim SE, Nicholas E, Chandler M, Ngo-Metzger Q, Paigne K, Paigne S, Nguyen DV, Sorkin DH (2016) Rationale and study protocol for a multi-component health information technology (HIT) screening tool for depression and post-traumatic stress disorder in the primary care setting. Contemp Clin Trials, 50:66-76.
  10. Ligsay A, Dijck AV, Nguyen DV, Lozano R, Chen Y, Bickel E, Hessl DR, Schneider A, Angkustsiri K, Tassone F, Kooy RF, Hagerman RJ (2017) A randomized double-blind, placebo-controlled trial of ganaxolone in children and adolescents with fragile X syndrome. Journal of Neurodevelopmental Disorders, 9(1):26.
  11. Sorkin DH, Rook KS, Campos B, Solares J, Mukamel D, Marcus B, Marquez B, Kilgore D, Dow E, Ngo-Metzger Quyen, Nguyen DV, Biegler K (2018) Rationale and study protocol for a Unidas por la Vida (United for Life): A weight-loss intervention for high-risk Latina mothers and their adult daughters. Contemp Clin Trials, 69:10-20.
  12. Sorkin DH, Rizzo S, Biegler K, Sim SE, Nicholas E, Chandler M, Ngo-Metzger Quyen, Paigne K, Nguyen DV, Molllica R (2019) Novel health information technology to aid provider recognition and treatment of major depressive and post-traumatic stress disorder (PTSD) in the primary care setting. Medical Care, 6, 2:S190-S196.
  13. Hessl D, Schweitzer J, Nguyen DV, McLennan YA, Johnston C, Shickman R, Chen Y (2019) Cognitive training for children and adolescents with fragile X syndrome: A randomized controlled trial of Cogmed. Journal of Neurodevelopmental Disorders, 11(1):4, 1-14.
  14. Potter LA, Scholze DA, Biag H, Schneider A, Chen Y, Nguyen DV, Rajaratnam A, Rivera SM, Dwyer PS, Tassone F, Choudhary NS, Salcedo-Arellano JM, Hagerman RJ (2019) A randomized controlled trial of sertraline in young children with autism spectrum disorder. Frontiers in Psychiatry, 10:810.
  15. Tayek J, Stolz AA, Nguyen D, Fleischman MW, Donovan JA, Alcorn JM, Chao DC-K, Asghar A, Morgan T, and the Southern California Alcoholic Hepatitis Consortium (2022) A phase II, multicenter, open-label, randomized trial of pegfilgrastim for patients with alcohol-related hepatitis. eClinicalMedicine, 54: 101689 (p.1-11).